A Few Thoughts Regarding The actual Near Future Of Ceftiofur
?1) each responsible for the peer review and revision process of their assigned manuscripts. A virologist, Tatjana Avsic Zupano (Ljubljana- Slovenia), will soon be joining the team, to help manage the increasing number of submissions http://www.selleckchem.com/products/3-methyladenine.html the journal is receiving in this area. The responsibilities of the CMI Scientific Committee formerly titled the Editorial Board are in the process of being redefined. In the first instance, an important contribution they can make is to act reviewers. This support is very important at a time when it is becoming a significant challenge to secure agreement from sufficient reviewers. One of the most important developments for CMI has been the creation of ��publication��s by theme��, which seems to have been a great success (Table?1). Moreover, the journal��s style and brand has evolved. The journal has a modern cover design with images that rotate each issue and reflect the theme section. To assist the reader in navigating the articles in an issue, the table of contents appears on the back cover arranged by theme: bacteriology, virology, infectious diseases and epidemiology. In terms of the journal��s coverage up until 2007, most of the articles were related to resistance to antibiotics or physiopathology; however, these two elements have become minor. Therefore, there has been a very important change with CMI presenting more original research on clinical virology, mycology, infectious diseases and epidemiology. One of the future objectives is to publish more articles relating to parasitology and tropical PDGFR inhibitor diseases which are, associated with Ceftiofur travel medicine, because this is becoming a most important area. To meet these new challenges, the Scientific Committee will be modified during 2011. The type of articles submitted to CMI over the past 3?years has evolved (Table?2). The acceptance rate of original articles has gone from 18% in 2008 to 27% in 2009 and 23% in 2010 YTD. This is mainly a consequence of the increased quality of submitted papers. One important element is that we currently receive many articles from abroad. The majority of submissions originate from Europe (63.29%), Asia (19.30%) and then North America (7.15%) (detailed report in Table?3). Among the articles that have been the most popular, the 10 most cited since the official start of the new team, that is to say, from the January 2009 issue are shown in Table?4. Among articles of the theme section, the 10 most quoted from 2009 are shown in Table?5. The average citation rate for CMI reviews published in the first 6?months of 2009 is 6.4 compared with an average citation rate for Lancet infectious disease reviews of 15.3 published in the same period (i.e. first 6?months of 2009).
